Our Research

Discover our recent findings, catch up with news, and review in-depth resources.

Strategies for ADC Bioanalysis: Building for Complexity, Designing for the Future | Resolian

Blog

Strategies for ADC Bioanalysis: Building for Complexity, Designing for the Future

Resolian’s Andy Xue on what makes ADC bioanalysis uniquely demanding, and how the team builds scalable, drug-tolerant methods across ADCs, PDCs, and AOCs.
Read more
LC-MS for Protein Biomarkers: Precision Where Immunoassays Fall Short | Resolian

Blog

LC-MS for Protein Biomarkers: Precision Where Immunoassays Fall Short

Resolian’s Ashley Phillips on why LC-MS outperforms immunoassays for protein biomarkers, from isoform differentiation to drug-tolerant assay design.
Read more
Direct to qPCR Case Study

Case Studies

Faster, Simpler Oligonucleotide Quantitation: An Extraction-Free qPCR Workflow for Tissue and Plasma

Resolian developed and validated an MSD-based bridging ECLIA method for analysing anti-drug antibodies against a GalNAc-conjugated siRNA therapeutic, evaluating both MSD and Gyrolab platforms for different GalNAc-conjugated siRNA therapeutics and providing a practical framework for immunogenicity assay development in this novel modality.
Read more
One Picogram Per Millilitre: Quantifying Free MMAE in Human Plasma for ADC Clinical Studies

Case Studies

One Picogram Per Millilitre: Quantifying Free MMAE in Human Plasma for ADC Clinical Studies

Resolian developed and validated an MSD-based bridging ECLIA method for analysing anti-drug antibodies against a GalNAc-conjugated siRNA therapeutic, evaluating both MSD and Gyrolab platforms for different GalNAc-conjugated siRNA therapeutics and providing a practical framework for immunogenicity assay development in this novel modality.
Read more
Bioanalytical Partner for Biopharma Startups: 5 Proven Selection Criteria. Resolian

Blog

Bioanalytical Partner for Biopharma Startups: 5 Proven Selection Criteria

Choosing a bioanalytical partner for biopharma startups? Follow these 5 proven criteria to protect your timeline, data quality, and regulatory readiness.
Read more
Correlative Light Microscopy and SEM Case Study - Resolian Analytical Sciences

Case Studies

From a Butterfly Wing to Nanoscale Structure: What Correlative Microscopy Reveals

See how Resolian pairs light microscopy and SEM to reveal structure from macro view to nanoscale, and what this means for your next investigation.
Read more
Scroll to Top
Zhao. Resolian Bioanalytics and Analytical Sciences.

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett. Resolian Bioanalytics and Analytical Sciences.

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.